The Role of Kidney Injury Biomarkers in COVID-19

Overview

Journal Ren Fail

Publisher Informa Healthcare

Date 2022 Aug 5

PMID 35930243

Authors

Lianjiu Su

Jiahao Zhang

Zhiyong Peng

Affiliations

Soon will be listed here.

Abstract

The coronavirus disease-2019 (COVID-19) outbreak has been declared a global pandemic. COVID-19-associated acute kidney injury (COVID-19 AKI) is related to a high mortality rate and serves as an independent risk factor for hospital death in patients with COVID-19. Early diagnosis would allow for earlier intervention and potentially improve patient outcomes. The goal of early identification of AKI has been the primary impetus for AKI biomarker research, and several kidney injury biomarkers have been demonstrated to be beneficial in predicting COVID-19 AKI as well as disease progression in COVID-19. Furthermore, such data provide valuable insights into the molecular mechanisms underlying this complex and unique disease and serve as a molecular phenotyping tool that could be utilized to direct clinical intervention. This review focuses on a number of kidney injury biomarkers, such as CysC, NAGAL, KIM-1, L-FABP, IL-18, suPAR, and [TIMP-2] • [IGFBP7], which have been widely studied in common clinical settings, such as sepsis, cardiac surgery, and contrast-induced AKI. We explore the role of kidney injury biomarkers in COVID-19 and discuss what remains to be learned.

Citing Articles

Biomarker states and risk of death among individuals hospitalized with SARS-CoV-2 infection.

Thaweethai T, Selvaggi C, Ng T, Cheng D, Cao T, Chibnik L BMC Infect Dis. 2025; 25(1):260.

PMID: 39994606 PMC: 11849268. DOI: 10.1186/s12879-025-10651-w.

Clustering based on renal and inflammatory admission parameters in critically ill patients admitted to the ICU.

Mascle O, Dupuis C, Brailova M, Bonnet B, Mirand A, Chauvot de Beauchene R PLoS One. 2024; 19(11):e0307938.

PMID: 39485788 PMC: 11530013. DOI: 10.1371/journal.pone.0307938.

Research on the global trends of COVID-19 associated acute kidney injury: a bibliometric analysis.

Zhao W, Tan R, Gao J, Su H, Wang L, Liu J Ren Fail. 2024; 46(1):2338484.

PMID: 38832469 PMC: 11262241. DOI: 10.1080/0886022X.2024.2338484.

Kidney damage associated with COVID-19: from the acute to the chronic phase.

Nlandu Y, Tannor E, Bafemika T, Makulo J Ren Fail. 2024; 46(1):2316885.

PMID: 38561236 PMC: 10986440. DOI: 10.1080/0886022X.2024.2316885.

Acute kidney injury in critical COVID-19 patients: usefulness of urinary biomarkers and kidney proximal tubulopathy.

Larcher R, Bargnoux A, Badiou S, Besnard N, Brunot V, Daubin D Ren Fail. 2023; 45(2):2292152.

PMID: 38078385 PMC: 11001358. DOI: 10.1080/0886022X.2023.2292152.

References

Melnikov V, Ecder T, Fantuzzi G, Siegmund B, Lucia M, Dinarello C . Impaired IL-18 processing protects caspase-1-deficient mice from ischemic acute renal failure. J Clin Invest. 2001; 107(9):1145-52. PMC: 209282. DOI: 10.1172/JCI12089. View

Tantry U, Bliden K, Cho A, Walia N, Dahlen J, Ens G . First Experience Addressing the Prognostic Utility of Novel Urinary Biomarkers in Patients With COVID-19. Open Forum Infect Dis. 2021; 8(7):ofab274. PMC: 8194603. DOI: 10.1093/ofid/ofab274. View

Vogel M, Mustroph J, Staudner S, Leininger S, Hubauer U, Wallner S . Kidney injury molecule-1: potential biomarker of acute kidney injury and disease severity in patients with COVID-19. J Nephrol. 2021; 34(4):1007-1018. PMC: 8190170. DOI: 10.1007/s40620-021-01079-x. View

Varga Z, Flammer A, Steiger P, Haberecker M, Andermatt R, Zinkernagel A . Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020; 395(10234):1417-1418. PMC: 7172722. DOI: 10.1016/S0140-6736(20)30937-5. View

Vasquez-Bonilla W, Orozco R, Argueta V, Sierra M, Zambrano L, Munoz-Lara F . A review of the main histopathological findings in coronavirus disease 2019. Hum Pathol. 2020; 105:74-83. PMC: 7395947. DOI: 10.1016/j.humpath.2020.07.023. View

Katagiri D, Ishikane M, Asai Y, Kinoshita N, Ota M, Moriyama Y . Evaluation of Coronavirus Disease 2019 Severity Using Urine Biomarkers. Crit Care Explor. 2020; 2(8):e0170. PMC: 7402421. DOI: 10.1097/CCE.0000000000000170. View

Ahmadian E, Hosseiniyan Khatibi S, Soofiyani S, Abediazar S, Shoja M, Ardalan M . Covid-19 and kidney injury: Pathophysiology and molecular mechanisms. Rev Med Virol. 2020; 31(3):e2176. PMC: 7646060. DOI: 10.1002/rmv.2176. View

Ambivero C, Cilenti L, Main S, Zervos A . Mulan E3 ubiquitin ligase interacts with multiple E2 conjugating enzymes and participates in mitophagy by recruiting GABARAP. Cell Signal. 2014; 26(12):2921-9. DOI: 10.1016/j.cellsig.2014.09.004. View

Braun F, Lutgehetmann M, Pfefferle S, Wong M, Carsten A, Lindenmeyer M . SARS-CoV-2 renal tropism associates with acute kidney injury. Lancet. 2020; 396(10251):597-598. PMC: 7431179. DOI: 10.1016/S0140-6736(20)31759-1. View

10.

Freeman B, Raue H, Hill A, Slifka M . Cytokine-Mediated Activation of NK Cells during Viral Infection. J Virol. 2015; 89(15):7922-31. PMC: 4505636. DOI: 10.1128/JVI.00199-15. View

11.

Wallbach M, Tampe B, Dihazi H, Koziolek M . [Acute kidney injury: from creatinine to KIM‑1?]. Internist (Berl). 2019; 60(6):578-586. DOI: 10.1007/s00108-019-0602-y. View

12.

Sier C, Sidenius N, Mariani A, Aletti G, Agape V, Ferrari A . Presence of urokinase-type plasminogen activator receptor in urine of cancer patients and its possible clinical relevance. Lab Invest. 1999; 79(6):717-22. View

13.

Klein S, Brandtner A, Lehner G, Ulmer H, Bagshaw S, Wiedermann C . Biomarkers for prediction of renal replacement therapy in acute kidney injury: a systematic review and meta-analysis. Intensive Care Med. 2018; 44(3):323-336. PMC: 5861176. DOI: 10.1007/s00134-018-5126-8. View

14.

Farkash E, Wilson A, Jentzen J . Ultrastructural Evidence for Direct Renal Infection with SARS-CoV-2. J Am Soc Nephrol. 2020; 31(8):1683-1687. PMC: 7460898. DOI: 10.1681/ASN.2020040432. View

15.

Gerard A, Laurain A, Fresse A, Parassol N, Muzzone M, Rocher F . Remdesivir and Acute Renal Failure: A Potential Safety Signal From Disproportionality Analysis of the WHO Safety Database. Clin Pharmacol Ther. 2020; 109(4):1021-1024. DOI: 10.1002/cpt.2145. View

16.

Su L, Li Y, Kellum J, Peng Z . Predictive value of cell cycle arrest biomarkers for cardiac surgery-associated acute kidney injury: a meta-analysis. Br J Anaesth. 2018; 121(2):350-357. DOI: 10.1016/j.bja.2018.02.069. View

17.

Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J . Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA. 2020; 323(11):1061-1069. PMC: 7042881. DOI: 10.1001/jama.2020.1585. View

18.

Bagshaw S, Langenberg C, Haase M, Wan L, May C, Bellomo R . Urinary biomarkers in septic acute kidney injury. Intensive Care Med. 2007; 33(7):1285-1296. DOI: 10.1007/s00134-007-0656-5. View

19.

South A, Tomlinson L, Edmonston D, Hiremath S, Sparks M . Controversies of renin-angiotensin system inhibition during the COVID-19 pandemic. Nat Rev Nephrol. 2020; 16(6):305-307. PMC: 7118703. DOI: 10.1038/s41581-020-0279-4. View

20.

Reisinger A, Niedrist T, Posch F, Hatzl S, Hackl G, Prattes J . Soluble urokinase plasminogen activator receptor (suPAR) predicts critical illness and kidney failure in patients admitted to the intensive care unit. Sci Rep. 2021; 11(1):17476. PMC: 8410930. DOI: 10.1038/s41598-021-96352-1. View